Exacerbated GSK‐3β activity is also present in other peroxisomal diseases, like rhizomelic chondrodysplasia punctata, in which plasmalogen deficiency leads to AKT inactivation and GSK‐3β activation (da Silva et al, 2014). The gene discussed is AKT1; the disease is peroxisomal disease.